Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells

Chinese Journal of Oncology

Volumn 33, Issue 12, 2011, Pages 891-895

  Chen, Zu Jin ^a   Zhang, Bin ^a   Pan, Si Hu ^a   Zhao, Hong Meng ^a   Zhang, Yue ^a   Feng, Wei Hong ^a   Li, Yuan Yuan ^a   Cao, Xu Chen ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

ABT 737; Apoptosis; Breast neoplasms; Cisplatin

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CASPASE 3; CISPLATIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IC 50; IN VITRO STUDY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BIPHENYL COMPOUNDS; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; HUMANS; NITROPHENOLS; PIPERAZINES; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFONAMIDES;

EID: 84862957563     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.12.003     Document Type: Article

References (15)

1. Willis SN, Fletcher JI, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science, 2007, 315:856-859.
2. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 2007, 26:1324-1337. (Pubitemid 46328466)
3. Li R, Zang Y, Li C, et al. ABT-737 synergizes with chemotherapy to kill head and neck squamous cell carcinoma cells via a Noxa-mediated pathway. Mol Pharmacol, 2009, 75:1231-1239.
4. Hikita H, Takehara T, Shimizu S, et al. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hepatology, 2010, 52:1310-1321.
5. Lieber J, Kirchner B, Eicher C, et al. Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells. Pediatr Blood Cancer, 2010, 55:1089-1095.
6. Mason KD, Khaw SL, Rayeroux KC, et al. The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia. Leukemia, 2009, 23:2034-2041.
7. Mohran TZ. Gemcitabine and cisplatin combination chemotherapy as a first-line treatment in patients with metastatic breast cancer. J Egypt Natl Canc Inst, 2004, 16:8-14.
8. Chew HK, Doroshow JH, Frankel P, et al. Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer. J Clin Oncol, 2009, 27:2163-2169.
9. Vassilomanolakis M, Koumakis G, Barbounis V, et al. First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer. Breast, 2005, 14:136-141. (Pubitemid 40353041)
10. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003, 22:7265-7279. (Pubitemid 37487159)
11. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 2005, 435:677-681. (Pubitemid 40825512)
12. Hann CL, Daniel VC, Sugar EA, et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res, 2008, 68:2321-2328. (Pubitemid 351521806)
13. Del Gaizo Moore V, Schlis KD, Sallan SE, et al. BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia. Blood, 2008, 111:2300-2309. (Pubitemid 351451437)
14. Kline MP, Rajkumar SV, Timm MM, et al. ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells. Leukemia, 2007, 21:1549-1560. (Pubitemid 46965297)
15. Certo M, Del Gaizo Moore V, Nishino M, et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. Cancer Cell, 2006, 9:351-365. (Pubitemid 43668734)